NovaBay Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova lid and lash hygiene for the domestic eye care market, announces that it has regained compliance with NYSE American continued listing standards. “We view the ability to maintain compliance with the NYSE as a vote of confidence from shareholders in our Avenova commercialization strategy and the prospect for NovaBay going forward,”